Page last updated: 2024-09-05

sb 216763 and Scleroderma, Systemic

sb 216763 has been researched along with Scleroderma, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akhmetshina, A; Bergmann, C; Beyer, C; Dees, C; Distler, JH; Distler, O; Palumbo, K; Schett, G; Zerr, P; Zwerina, J	1

Other Studies

1 other study(ies) available for sb 216763 and Scleroderma, Systemic

Article	Year
Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway. Annals of the rheumatic diseases, 2011, Volume: 70, Issue:12 Topics: Animals; Bleomycin; Cells, Cultured; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Fibroblasts; Fibrosis; Gene Knockdown Techniques; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Male; Maleimides; Mice; Mice, Inbred DBA; RNA, Small Interfering; Scleroderma, Systemic; Skin; Wnt Signaling Pathway	2011

Article

Year

Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway.

Annals of the rheumatic diseases, 2011, Volume: 70, Issue:12

Topics: Animals; Bleomycin; Cells, Cultured; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Fibroblasts; Fibrosis; Gene Knockdown Techniques; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Male; Maleimides; Mice; Mice, Inbred DBA; RNA, Small Interfering; Scleroderma, Systemic; Skin; Wnt Signaling Pathway

2011